CN1808106A - Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance - Google Patents
Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance Download PDFInfo
- Publication number
- CN1808106A CN1808106A CN 200510023500 CN200510023500A CN1808106A CN 1808106 A CN1808106 A CN 1808106A CN 200510023500 CN200510023500 CN 200510023500 CN 200510023500 A CN200510023500 A CN 200510023500A CN 1808106 A CN1808106 A CN 1808106A
- Authority
- CN
- China
- Prior art keywords
- substrate
- proton
- acetylcholinesterase
- enzyme
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention provides a method for screening cholinesterase inhibitor, which comprises: testing the relaxation rates of sample compounds in substrate before and after adding acetylcholinesterase to decide the sample compounds which relaxation rates being speed-up as the cholinesterase inhibitor; at the same time, employing double irradiation method to get the prolonged movement time of the substrate molecule; the nuclear magnetic resonance of the substrate proton before and after adding enzyme having no obvious change if the substrate molecule haven't combined with the enzyme.
Description
Technical field
The present invention relates to a kind of screening technique of acetylcholinesteraseinhibitors inhibitors, more particularly, relate to the method that a kind of using NMR screens acetylcholinesteraseinhibitors inhibitors.
Background technology
Alzheimer's disease (Alzheimer disease) be a kind of be the carrying out property mental illness of feature with the memory defects.The change of central cholinergic system transmission mechanism is the most significant pathology of alzheimer's disease patient central nervous system, and relevant with the seriousness of dementia.Present medicine is first-selected with the anticholinesterase.The function of acetylcholinesterase is the hydrolysis acetylcholine, makes its inactivation, and then the normal physiological function of the cynapse that affects the nerves.Anticholinesterase can delay the hydrolysis of acetylcholine, improves the content of acetylcholine in synaptic cleft, thereby keeps the normal physiological function of nervous centralis cynapse, produces result of treatment.But screening technique commonly used at present is, with from rat cerebral cortex, separating the acetylcholinesterase (AChE) obtain as screening model, add sample compound, develop the color with Ellman ' s reagent again, compare by colourimetry, try to achieve inhibiting activity of acetylcholinesterase, No. the 1417209th, Chinese invention patent application specification (for example, can referring to) thus.
Yet the shortcoming of colorimetric method is need with more enzyme amount, and colour developing to be interfered easily.
Summary of the invention
The objective of the invention is, be to seek a kind of fast and simple, method of not being subject to the screening acetylcholinesterase inhibitor that disturbs.
The screening technique of acetylcholinesteraseinhibitors inhibitors of the present invention adopts the means of nuclear magnetic resonance, screens effective acetylcholinesteraseinhibitors inhibitors by the bonding state of observing sample compound molecule and acetylcholinesterase.
Promptly, the present invention finishes on the basis of following experiment: add acetylcholinesterase in the solution as the sample compound of substrate, observe the variation of the relaxation properties of the sample compound proton that adds the acetylcholinesterase front and back, combine with enzyme as substrate molecule, then the selectivity relaxation rate of substrate proton accelerates, simultaneously, it is elongated to record the relevant run duration of substrate molecule by the double irradiation method; Combine with enzyme as substrate molecule, then the proton of substrate does not have significant change in the nuclear magnetic resonance character of enzyme-added front and back.
Therefore, the invention provides a kind of like this method of screening acetylcholinesteraseinhibitors inhibitors, it determines that by measuring the relaxation rate of sample compound before and after the adding acetylcholinesterase as substrate the sample compound that the selectivity relaxation rate accelerates is an acetylcholinesteraseinhibitors inhibitors.
In said method, described assay method can adopt the upset restoring method.Promptly use 180 degree pulses and make the proton magnetic vector upset that will observe, the recovery extent of observation magnetic vector after the different stand-by period is according to judging magnetic Henan speed the release time of magnetic vector.
The non-selective spin lattice speed of proton (hereinafter to be referred as the speed of relaxing) R
NsThe relaxation rate of each proton when shining all protons in the molecule simultaneously.The selectivity spin lattice speed R of proton
sBe the relaxation rate of this proton during specific proton in the irradiation molecule.R
NsAnd R
sSatisfy following equation:
In equation (1), (2), ρ ij is H
iWhen after proton is illuminated energy being given other proton of its mutual dipole to the contribution of relaxation rate.σ ij is that two protons of mutual dipole influence each other to the contribution of relaxation rate, ρ after simultaneously illuminated
i *For other relaxation mechanism to H
iThe influence of relaxation rate.Relatively (1), (2) can be found out, in (2) formula, and R
sOwing to only shine H
iProton is not so have other illuminated proton to H
iInfluence item σ ij.
Be further to detect huperzine and the intermolecular interaction of torpedo acetylcholinesterase TnAChE, the method that we use double irradiation has been measured the relevant run duration of molecule.From equation (1), (2) as can be known, the fast σ ij=R that relaxes of the intersection between proton
i Ij-R
i s, R
i IjFor shining H simultaneously
iReach proton H with its coupling
jThe time H that records
iThe speed of speeding of proton.R
sFor shining H in the irradiation molecule separately
iThe time this proton relaxation rate.When enzyme-to-substrate mutually combined, exists a mobile equilibrium system, set up following equation (3) and (4):
In the formula, p
FreeBe the substrate ratio of desmoenzyme not in the solution, p
BoundBe the ratio of the substrate of desmoenzyme, σ
Free IjObserved cross-relaxation rate when not enzyme-added, σ
Bound IjBe the cross-relaxation rate under the pure enzyme bonding state that calculates.
When considering σ with the most conservative method
Bound IjWith σ f
Ree Ij, promptly set enzyme-to-substrate combination completely, then p taken place
Bound=(protein)/(ligand), p
Free=1-p
BoundCalculate σ according to equation (4) again
Bound IjValue, use molecular motion τ correlation time
Bound IjWith σ
Bound IjBetween relational equation (5), can draw substrate and enzyme in conjunction with after the relevant run duration of molecule.
In the formula, σ
Bound IjBe the cross-relaxation rate under the pure enzyme bonding state that calculates, σ
Bound IjBe the cross-relaxation rate under the pure enzyme bonding state that calculates, σ
Free IjObserved cross-relaxation rate when not enzyme-added, P
BoundBe the ratio of the substrate of desmoenzyme, γ is the magnetic rotation ratio of proton,
Be the modified value of Plank ' s constant,
r
IjBe proton H
iAnd the distance between Hj, be H
iMove correlation time with Hj, ω is the Larmor frequency of proton.
In the method for the invention, can revolve lattice speed R in vain according to the proton selectivity of substrate behind the adding acetylcholinesterase
sIncrement whether greater than its non-selective spin lattice speed R
NsIncrement determine effective acetylcholinesteraseinhibitors inhibitors.
In addition, in the method for the invention, can be when adding acetylcholinesterase the proton selectivity spin lattice speed R of substrate
sProton selectivity spin lattice speed R during greater than the adding butyrylcholine esterase
sDetermine effective acetylcholinesteraseinhibitors inhibitors.
In addition, in the method for the invention, can also determine effective acetylcholinesteraseinhibitors inhibitors according to the relevant run duration ω τ of molecule that adds substrate behind the acetylcholinesterase is whether elongated.
The relevant run duration ω τ of described molecule is elongated for example to be from being converted into greater than 1 less than 1.
The advantage of this method is 1, and is easy to be quick: testing sample and enzyme are put together, and directly using NMR instrument test can be seen obvious result in 10 minutes.Need not harsh test condition and reagent etc.2, real-time: be dissolved in the observation of carrying out in the damping fluid of internal milieu with testing molecule that combines because of enzyme, thus the method can detect enzyme under coenocorrelation, solution state with the combining of substrate.3, can once screen the situation that a plurality of compositions combine with enzyme, according to the change situation of the NMR signal of each enzyme-added front and back of composition, find out the molecule that combines with enzyme.
Embodiment
Huperzine is at first to separate a kind of natural products that obtains by China scientist from the Chinese herbal medicine Huperzia serrata, after measured, it is the reversible inhibitor of acetylcholinesterase, characteristics such as have the selectivity height, toxicity is low and EDD is long are to treat the comparatively desirable drug candidate of senile dementia so far in the world.
In the present invention, the present inventor with huperzine, the same alkaloid Huperzine B that obtains and the 8-hydroxyl phlegmariurine B of from Huperzia serrata, separating as sample compound.
The huperzine Huperzine B
8-hydroxyl phlegmariurine B
Embodiment 1: the preparation of analytical sample and test
Huperzine, Huperzine B and 8-hydroxyl phlegmariurine B system extract from the medicinal plant serrate clubmoss herb and obtain, and purify with HPLC, and purity is all more than 99%.
Used acetylcholinesterase is Chinese Ding Shi Narcine brasiliensis acetylcholinesterase, is obtained through the separation and purification of affinity chromatography method by the electric ray electric organ, and it decomposes the acetylcholine activity and passes through colorimetric method for determining.
Butyrylcholine esterase: purchase company in Sigma.
It is pure that used analytical reagent is all analysis.
The sample preparation: huperzine is dissolved in the heavy water phosphate buffer of 20-100mM pH7.0, adding contains the 50mM pH7.0 heavy water phosphate buffer of acetylcholinesterase again, is mixed with to contain huperzine 1 μ mol/ml+ acetylcholinesterase 5 * 10
-3The enzyme-added sample of μ mol/ml.In addition, replace above-mentioned enzyme liquid as blank, make not enzyme-added sample contain huperzine 1 μ mol/ml with the 50mM pH7.0 heavy water phosphate buffer that does not contain acetylcholinesterase.
Use the same method and prepare the analytical sample of Huperzine B and 8-hydroxyl phlegmariurine B.
NMR analyzes: all experiments are carried out with 298K on the Varian Inova of U.S. Varian company 600NMR spectrometer.Chemical shift is calibrated with DSS (4,4-dimethyl-4-sila penta sodium sulfonate).It (is effective, the easiest method that the relaxation time of proton is used upset restoring method mensuration.Relaxation rate is tried to achieve by indicial equation.
Embodiment 2: substrate is measured determining of concentration
The difference of the polymerization state of substrate molecule in solution can cause the change of chemical shift, and simultaneously polymerization state also can influence the relaxation time of proton in the substrate, thereby has influence on the mensuration of the relaxation rate after enzyme-added.
For this reason, the chemical shift of substrate molecule under the variable concentrations when needing measurement not enzyme-added is to determine the substrate polymerization state.Change (Fig. 2) by the H3 chemical shift of proton of observing the huperzine in 0.2~30.0mM scope, discovery is increased with concentration, and the H3 proton chemical shifts is to high field displacement.The generation of aggregative state is described, but under≤1mM concentration, molecule exists with single poly-attitude.So determine under the concentration of≤1mM, to measure the relaxation rate of huperzine, so that the relaxation rate that records is not subjected to the influence of molecule aggregation state.Huperzine B and 8-hydroxyl phlegmariurine B are also measured under similarity condition.
Embodiment 3: the mensuration of substrate molecule movement rate
The non-selective spin lattice speed of proton (hereinafter to be referred as the speed of relaxing) R
NsThe relaxation rate of each proton when shining all protons in the molecule simultaneously.The selectivity spin lattice speed R of proton
sBe the relaxation rate of this proton during specific proton in the irradiation molecule.R
NsAnd R
sSatisfy following equation:
In equation (1), (2), ρ ij is H
iWhen after proton is illuminated energy being given other proton of its mutual dipole to the contribution of relaxation rate.σ ij is that two protons of mutual dipole influence each other to the contribution of relaxation rate, ρ after simultaneously illuminated
i *For other relaxation mechanism to H
iThe influence of relaxation rate.Relatively (1), (2) can be found out, in (2) formula, and R
sOwing to only shine H
iProton is not so have other illuminated proton to H
iInfluence item σ ij.
In the present embodiment, we have observed huperzine, Huperzine B and acetylcholinesterase, the H2 when butyrylcholine esterase combines in huperzine, the Huperzine B, H3, H7/H8, the relaxation rate of M10 and M16 proton.Other proton is because chemical shift overlapped (as H8, H11) or be multiplet type (as H6, H14 is an AB system peak type with carbonaceous son), can't select suitable 180 to spend soft pulses and shine and ignore.The relaxation speed value of tested proton is shown in the table 1,2.Experimental result shows, enzyme-added front and back, and chemical shift of proton does not have significant change, that is and, chemical shift of proton is not subjected to enzyme-added influence (concrete data not shown goes out), but the relaxation rate of nearly all proton is enhanced after enzyme-added.And, R
sStrengthen obviously greater than R
NsThis be because when micromolecule with after big molecule combine, σ ij value often is a negative value, due to the feasible fast enhancing of relaxation that is brought by ρ ij is cancelled.R
sObviously strengthen and illustrate that substrate huperzine, Huperzine B have all taken place to combine with enzyme.R
sInfluence be H7=H3>H2>M16>M10 in proper order, show that the unsaturated carbonyl conjugate ring part in huperzine, the Huperzine B is strong with the albumen effect.Relatively huperzine, Huperzine B respectively with acetylcholinesterase, R when butyrylcholine esterase combines
s, can find the R that huperzine, Huperzine B combine with acetylcholinesterase
sThe R that value generally combines with butyrylcholine esterase greater than huperzine, Huperzine B
sValue illustrates that the bond strength of huperzine, Huperzine B and acetylcholinesterase is bigger.
Embodiment 4: the mensuration of cross relaxation speed and the relevant run duration of molecule
Be further to detect huperzine and the intermolecular interaction of torpedo acetylcholinesterase TnAChE, the method that we use double irradiation has been measured the relevant run duration of molecule.From equation (1), (2) as can be known, the fast σ ij=R that relaxes of the intersection between proton
i Ij-R
i s, R
i IjFor shining H simultaneously
iReach proton H with its coupling
iThe time H that records
jThe speed of speeding of proton.R
sFor shining H in the irradiation molecule separately
iThe time this proton relaxation rate.When enzyme-to-substrate mutually combined, exists a mobile equilibrium system, set up following equation (3) and (4):
In the formula, p
FreeBe the substrate ratio of desmoenzyme not in the solution, p
BoundBe the ratio of the substrate of desmoenzyme, σ
Free IjObserved cross-relaxation rate when not enzyme-added, σ
Bound IjBe the cross-relaxation rate under the pure enzyme bonding state that calculates.
When considering σ with the most conservative method
Bound IjWith σ
Free Ij, promptly set enzyme-to-substrate combination completely, then p taken place
Bound=(protein)/(ligand), p
Free=1-p
BoundCalculate σ according to equation (4) again
Bound IjValue, use molecular motion τ correlation time
Bound IjWith σ
Bound IjBetween relational equation (5), can draw substrate and enzyme in conjunction with after the relevant run duration of molecule.
In the formula, σ
Bound IjBe the cross-relaxation rate under the pure enzyme bonding state that calculates, σ
Bound IjBe the cross-relaxation rate under the pure enzyme bonding state that calculates, σ
Free IjObserved cross-relaxation rate when not enzyme-added, p
BoundBe the ratio of the substrate of desmoenzyme, γ is the magnetic rotation ratio of proton,
Be the modified value of Plank ' s constant,
r
IjBe proton H
iAnd the distance between Hj, be H
iMove correlation time with Hj, ω is the Larmor frequency of proton.In this test, and our three group protons adjacent to huperzine (H2-H3, H7-H8 H10-H11) has carried out the double irradiation test, the results are shown in Table 3, wherein, cross-relaxation rate variable Δ σ
IjBe σ
Obs IjWith σ
Free IjBe the difference of the two.As can be seen, cross-relaxation rate σ
IjNext less from unbound state on the occasion of a bigger negative value that changes under the bonding state, illustrate that huperzine combines its molecular motion related rate of back and slows down with TnAChE, make that ω τ is that motion correlation time under the unit interval is from being converted into greater than 1 less than 1, here we calculate molecular motion correlation time as a reference with the H2-H3 proton
According to equation [5], calculate
Nanosecond (ns) is compared (τ is generally in psec (ps) scope) with combined state not, illustrates that huperzine and TnAChE have taken place to combine.
Comparative example 1: negative control test
When biological micromolecule adheres to protein surface, but not when being incorporated into the avtive spot of albumen, be subjected to the influence of albumen, influence micromolecular relaxation properties thereby can cause micromolecular motility that certain change takes place equally.In order to observe the avtive spot whether huperzine is incorporated into albumen veritably, get rid of because the illusion that the relaxation properties that adhesion causes changes, we observed from serrate clubmoss herb, get equally another with the huperzine molecular size is similar but the alkaloid that structure is different-8-hydroxyl phlegmariurine B in the change of the proton relaxation time that adds electric ray acetylcholinesterase front and back.Use and above-mentioned same experimental technique, the result shows, add before and after the TnAChE, and the 7H of 8-hydroxyl phlegmariurine B, the relaxation properties end of 16Me changes, when 8-hydroxyl phlegmariurine B does not combine with TnAChE, the R of 7H
s=1.211 ± 0.052s
-1, the R of 16Me
s=1.584 ± 0.064s
-1, 8-hydroxyl phlegmariurine B is with after TnAChE combines, the R of 7H
s=1.119 ± 0.0346s
-1, the R of 16Me
s=1.546 ± 0.076s
-1, relatively do not have significant difference in conjunction with the front and back result.Illustrate that 8-hydroxyl phlegmariurine B with TnAChE combination does not take place.
Table 1. have or do not have TnAChE (5 μ M) and butyrylcholine esterase (5 μ M) in the presence of the huperzine (1mM) that records
1H NMR P parameter (600MHz, solvent: D
2O, pH 7.0, T=298K)
Contrast | Acetylcholinesterase | Butyrylcholine esterase | |||||
Proton | δ(ppm) | R ns(s -1) | R s(s -1) | R ns(s -1) | R s(s -1) | R ns(s -1) | R s(s -1) |
H2 | 6.57 | 0.51 | 0.36 | 0.54 | 0.57 | 0.52 | 0.44 |
H3 | 7.89 | 0.66 | 0.48 | 0.68 | 0.74 | 0.57 | 0.58 |
H7 | 3.82 | 1.24 | 0.95 | 1.27 | 1.31 | 1.29 | 1.06 |
M10 | 1.76 | 1.26 | 1.04 | 1.21 | 1.23 | 1.17 | 1.10 |
M16 | 1.60 | 1.27 | 1.15 | 1.22 | 1.37 | 1.24 | 1.20 |
Table 2. have or do not have TnAChE (5 μ M) and butyrylcholine esterase (5 μ M) in the presence of the Huperzine B (1mM) that records
1H NMR P parameter (600MHz, solvent: D
2O, pH 7.0, T=298K)
Contrast | Acetylcholinesterase | Butyrylcholine esterase | |||||
Proton | δ(ppm) | R ns(s -1) | R s(s -1) | R ns(s -1) | R s(s -1) | R ns(s -1) | R s(s -1) |
H2 | 6.57 | 0.51 | 0.36 | 0.54 | 0.57 | 0.52 | 0.44 |
H3 | 7.89 | 0.66 | 0.48 | 0.68 | 0.74 | 0.57 | 0.58 |
H7 | 3.82 | 1.24 | 0.95 | 1.27 | 1.31 | 1.29 | 1.06 |
M10 | 1.76 | 1.26 | 1.04 | 1.21 | 1.23 | 1.17 | 1.10 |
Table 3. have or do not have acetylcholinesterase (5 μ M) in the presence of the huperzine (1mM) that records
1The relevant run duration of H NMR cross relaxation speed (600MHz, solvent: D with molecule
2O, pH 7.0, T=298K)
Proton is right | σ free ij(s -1) | σ obs ij(s -1) | Δσ ij(s -1) | σ bound ij(s -1) |
H 2-H 3 | 0.050 | -0.006 | -0.056 | -11.2 |
H 7-H 8 | 0.055 | 0.032 | -0.023 | -4.6 |
H 10-H 11 | 0.115 | 0.020 | -0.095 | -19.0 |
Claims (8)
1. method of utilizing nuclear magnetic resonance screening acetylcholinesteraseinhibitors inhibitors, it is characterized in that, it is by in the solution of mensuration as the sample compound of substrate, add acetylcholinesterase, the relaxation rate of enzyme acetylcholine front and back is changed, measure substrate molecule movement rate, cross-relaxation rate, the relevant run duration of molecule, determine that the sample compound that the selectivity relaxation rate accelerates is an acetylcholinesteraseinhibitors inhibitors.
2. method according to claim 1 is characterized in that, is heavy water phosphate buffering liquid concentration 20~100mM of 50 μ MPH=7.0 as the solution of the sample compound of substrate.
3. method according to claim 1 is characterized in that, adds acetylcholine esterase before the solution of the sample compound of substrate, measures the chemical shift of substrate molecule under variable concentrations when not enzyme-added, determines the substrate polymerization state.
4. method according to claim 1 is characterized in that, described assay method is the upset restoring method.
5. method according to claim 2 is characterized in that, behind the adding acetylcholinesterase, the increment of the proton selectivity spin lattice speed Rs of described acetylcholinesteraseinhibitors inhibitors is greater than its non-selective spin lattice speed R
NsIncrement.
6. method according to claim 1 is characterized in that, when adding acetylcholinesterase, and the proton selectivity spin lattice speed R of the proton selectivity spin lattice speed Rs of described acetylcholinesteraseinhibitors inhibitors when adding butyrylcholine esterase
s
7 methods according to claim 1 is characterized in that, behind the adding acetylcholinesterase, described acetylcholinesteraseinhibitors inhibitors is elongated with the relevant run duration ω τ of molecule that the double irradiation method records.
8. method according to claim 5 is characterized in that, described ω τ is from being converted into greater than 1 less than 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510023500 CN1808106B (en) | 2005-01-21 | 2005-01-21 | Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510023500 CN1808106B (en) | 2005-01-21 | 2005-01-21 | Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1808106A true CN1808106A (en) | 2006-07-26 |
CN1808106B CN1808106B (en) | 2010-11-24 |
Family
ID=36840121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510023500 Expired - Fee Related CN1808106B (en) | 2005-01-21 | 2005-01-21 | Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1808106B (en) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106814097A (en) * | 2017-03-22 | 2017-06-09 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CdSe nano-probes |
CN106841271A (en) * | 2017-02-23 | 2017-06-13 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on ZnO nano probe |
CN106885822A (en) * | 2017-03-31 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Co Pd Al O nano-probes |
CN106885817A (en) * | 2017-03-11 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Ni nano-probes |
CN106885820A (en) * | 2017-03-30 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Co Cr nano-probes |
CN106885819A (en) * | 2017-03-22 | 2017-06-23 | 南昌大学 | One kind is based on NaYF4The method that nano-probe screens anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs |
CN106885818A (en) * | 2017-03-22 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoZrO nano-probes |
CN106885821A (en) * | 2017-03-31 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Cu Ni nano-probes |
CN106918611A (en) * | 2017-02-23 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeZr nano-probes |
CN106918616A (en) * | 2017-03-31 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Co nano-probes |
CN106918614A (en) * | 2017-03-30 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on AlSb nano-probes |
CN106918615A (en) * | 2017-03-30 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on AlP nano-probes |
CN106918613A (en) * | 2017-02-23 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeZrO nano-probes |
CN106918612A (en) * | 2017-02-23 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe nano-probes |
CN106932428A (en) * | 2017-04-10 | 2017-07-07 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on TiO2 nano-probes |
CN106932427A (en) * | 2017-04-10 | 2017-07-07 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeAlO nano-probes |
CN106950239A (en) * | 2017-02-23 | 2017-07-14 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on ZnS nano-probes |
CN106950240A (en) * | 2017-02-23 | 2017-07-14 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on ZnSe nano-probes |
CN106970104A (en) * | 2017-04-10 | 2017-07-21 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Zr Cu B nano-probes |
CN106996943A (en) * | 2017-04-10 | 2017-08-01 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on NdFeB nano-probes |
CN107014848A (en) * | 2017-03-11 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeRh nano-probes |
CN107014851A (en) * | 2017-03-31 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeZrB nano-probes |
CN107014847A (en) * | 2017-02-23 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on NiPt nano-probes |
CN107014852A (en) * | 2017-04-10 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeSiCo nano-probes |
CN107037067A (en) * | 2017-03-22 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Co nano-probes |
CN107037068A (en) * | 2017-03-22 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoZr nano-probes |
CN107037069A (en) * | 2017-03-22 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoPt nano-probes |
CN107037201A (en) * | 2017-02-23 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on KMnF4 nano-probes |
CN107044990A (en) * | 2017-03-22 | 2017-08-15 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CdTe nano-probes |
CN107044989A (en) * | 2017-02-23 | 2017-08-15 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Ni nano-probes |
CN107044991A (en) * | 2017-03-30 | 2017-08-15 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoFeB nano-probes |
CN107064200A (en) * | 2017-03-31 | 2017-08-18 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeSi nano-probes |
CN107085004A (en) * | 2017-04-10 | 2017-08-22 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Ni Gd C nanos probe |
CN107144589A (en) * | 2017-04-10 | 2017-09-08 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Co Ni nano-probes |
CN107144590A (en) * | 2017-04-10 | 2017-09-08 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Ta Cu B nano-probes |
CN107179331A (en) * | 2017-04-10 | 2017-09-19 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Si Nb Cu nano-probes |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW263504B (en) * | 1991-10-03 | 1995-11-21 | Pfizer | |
CN1072722C (en) * | 1997-12-30 | 2001-10-10 | 中国科学院上海细胞生物学研究所 | Method of screening anti-tumour medicine and determining clinical chemotherapy effect |
CN1257901C (en) * | 2001-11-08 | 2006-05-31 | 中国科学院上海药物研究所 | Tetrahydroquinoline ketopiperidine compounds and their prepn and use |
-
2005
- 2005-01-21 CN CN 200510023500 patent/CN1808106B/en not_active Expired - Fee Related
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106918613A (en) * | 2017-02-23 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeZrO nano-probes |
CN106841271A (en) * | 2017-02-23 | 2017-06-13 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on ZnO nano probe |
CN106950240A (en) * | 2017-02-23 | 2017-07-14 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on ZnSe nano-probes |
CN107014847A (en) * | 2017-02-23 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on NiPt nano-probes |
CN106950239A (en) * | 2017-02-23 | 2017-07-14 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on ZnS nano-probes |
CN107044989A (en) * | 2017-02-23 | 2017-08-15 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Ni nano-probes |
CN106918611A (en) * | 2017-02-23 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeZr nano-probes |
CN107037201A (en) * | 2017-02-23 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on KMnF4 nano-probes |
CN106918612A (en) * | 2017-02-23 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe nano-probes |
CN107014848A (en) * | 2017-03-11 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeRh nano-probes |
CN106885817A (en) * | 2017-03-11 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Ni nano-probes |
CN106885819A (en) * | 2017-03-22 | 2017-06-23 | 南昌大学 | One kind is based on NaYF4The method that nano-probe screens anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs |
CN107044990A (en) * | 2017-03-22 | 2017-08-15 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CdTe nano-probes |
CN106814097A (en) * | 2017-03-22 | 2017-06-09 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CdSe nano-probes |
CN106885818A (en) * | 2017-03-22 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoZrO nano-probes |
CN107037069A (en) * | 2017-03-22 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoPt nano-probes |
CN107037068A (en) * | 2017-03-22 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoZr nano-probes |
CN107037067A (en) * | 2017-03-22 | 2017-08-11 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Co nano-probes |
CN106918615A (en) * | 2017-03-30 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on AlP nano-probes |
CN106918614A (en) * | 2017-03-30 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on AlSb nano-probes |
CN106885820A (en) * | 2017-03-30 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Co Cr nano-probes |
CN107044991A (en) * | 2017-03-30 | 2017-08-15 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on CoFeB nano-probes |
CN106918616A (en) * | 2017-03-31 | 2017-07-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Co nano-probes |
CN106885821A (en) * | 2017-03-31 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Cu Ni nano-probes |
CN107014851A (en) * | 2017-03-31 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeZrB nano-probes |
CN107064200A (en) * | 2017-03-31 | 2017-08-18 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeSi nano-probes |
CN106885822A (en) * | 2017-03-31 | 2017-06-23 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Co Pd Al O nano-probes |
CN106970104A (en) * | 2017-04-10 | 2017-07-21 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Zr Cu B nano-probes |
CN106932428A (en) * | 2017-04-10 | 2017-07-07 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on TiO2 nano-probes |
CN106932427A (en) * | 2017-04-10 | 2017-07-07 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeAlO nano-probes |
CN107014852A (en) * | 2017-04-10 | 2017-08-04 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on FeSiCo nano-probes |
CN106996943A (en) * | 2017-04-10 | 2017-08-01 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on NdFeB nano-probes |
CN107085004A (en) * | 2017-04-10 | 2017-08-22 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Ni Gd C nanos probe |
CN107144589A (en) * | 2017-04-10 | 2017-09-08 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Co Ni nano-probes |
CN107144590A (en) * | 2017-04-10 | 2017-09-08 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Ta Cu B nano-probes |
CN107179331A (en) * | 2017-04-10 | 2017-09-19 | 南昌大学 | A kind of method that anaerobic bacteria Inhibitors form Chinese Traditional Medicinal Herbs are screened based on Fe Si Nb Cu nano-probes |
Also Published As
Publication number | Publication date |
---|---|
CN1808106B (en) | 2010-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1808106A (en) | Method for screening acetylcholine esterase inhibitor by nuclear magnetic resonance | |
Impens et al. | Screening and confirmation of chloramphenicol in shrimp tissue using ELISA in combination with GC–MS2 and LC–MS2 | |
Prieto et al. | Synthesis of a molecularly imprinted polymer and its application for microextraction by packed sorbent for the determination of fluoroquinolone related compounds in water | |
DE102019120455B4 (en) | Method for the simultaneous determination of different analytes in an environmental sample, based on core / shell microparticles | |
CN109342632A (en) | The method that microwave abstracting-Solid Phase Extraction pre-treatment combination LC-MS technology detects 15 kinds of antibiotic in aquaculture bed mud simultaneously | |
Wan et al. | Determination of tetracyclines residues in honey using high-performance liquid chromatography with potassium permanganate–sodium sulfite–β-cyclodextrin chemiluminescence detection | |
Zhang et al. | Recent development in sample preparation and analytical techniques for determination of quinolone residues in food products | |
CN103837523B (en) | A kind of method detecting orthene and test kit | |
CN103543218B (en) | Method for measuring tetracycline antibiotic residue in protein-rich sample | |
EP1875250A2 (en) | Methods to measure immunosuppressive tacrolimus, sirolimus, and cyclosporin a complexes in a blood sample | |
Yao et al. | Determination of 11 quinolones in bovine milk using immunoaffinity stir bar sorptive microextraction and liquid chromatography with fluorescence detection | |
CN104634754A (en) | Method for detecting oxytetracycline (OTC) in food by virtue of functional magnetic bead isolation-enzyme linked aptamer | |
CN102033102A (en) | Method for screening beta-lactamase antibiotic decomposing agent in dairy products by high flux matrix assisted laser desorption ionization-mass spectrometry (MALDI-MS) | |
CN1693890A (en) | GC/MS inner scaling detection method for simultaneous investigating residual multiple organophosphorus in food | |
CN105954411A (en) | Determination method for absorption and transportation amount of six components in rhizoma bletillae in Caco-2 cell model | |
CN107782711B (en) | Surface-enhanced Raman spectroscopy sensor for detecting glycoprotein based on molecular imprinting polymer and preparation method and application thereof | |
CN105181823B (en) | A kind of method of methcathinone content in use high effective liquid chromatography for measuring sample | |
CN106370748B (en) | The assay method and its sample pretreating method of fluoroquinolones in organic fertilizer | |
Qiu et al. | A novel molecularly imprinted nanosensor based on quartz crystal microbalance for specific recognition of α-amanitin | |
CN1245629C (en) | Fluorescence polarizaton-based homogenous assay for aflatoxins | |
Jenne et al. | Focusing on “the important” through targeted NMR experiments: an example of selective 13 C–12 C bond detection in complex mixtures | |
EP2021800B1 (en) | Determination of changes in concentration | |
KR20080054955A (en) | Polydiacetylene sensor chip comprising protein and manufacturing process thereof | |
Reddy et al. | Development of a rapid and sensitive HPLC assay method for lenalidomide capsules and its related substances | |
Lee et al. | Immunostaining extracellular vesicles based on an aqueous two-phase system: For analysis of tetraspanins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101124 Termination date: 20120121 |